Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Category: Guides

Genomic Analysis

If you are a researcher, clinical geneticist, or bioinformatics student looking for a source bounded practical guide to genomic analysis, this article is for you. Genomic analysis is the computational process of reading, aligning, and interpreting DNA or RNA sequence data to identify variants, gene expression patterns, or structural changes. It transforms raw sequencing reads into biological insights that support studies in evolution, disease, agriculture, and personalized medicine. The key challenge is selecting the right methods and tools from a rapidly expanding ecosystem while avoiding pitfalls that lead to wasted time or false conclusions. The following guide, grounded in authoritative resources from NCBI Bookshelf, EMBL EBI Training, the Galaxy Training Network, and others, gives you a structured framework for any genomic analysis project [1, 3].

At its core, genomic analysis depends on a clear question and a realistic assessment of your data and computational capacity. Whether you are studying a rare disease variant in a human cohort, characterizing a viral isolate, or profiling gene families in a non model plant, the principles of quality control, alignment, variant detection, and filtering remain constant. This guide walks you through the foundational concepts, decision points, a step by step workflow, common mistakes, and the unavoidable limits of interpretation. By the end, you will have a checklist you can adapt to your specific application, supported by training materials and open source software from EMBL EBI and Bioconductor [2, 4].

At a Glance

Aspect Key Consideration
Core technologies Whole genome sequencing (WGS), whole exome sequencing (WES), RNA seq, targeted panels
Typical throughput 50 million to 1 billion reads per sample for WGS, 10,30 million for RNA seq
Most common reference GRCh38 (human), custom assemblies for non model organisms (see [10] for tradeoffs)
Essential quality metrics Per base Q score >= 30, mapping rate > 80%, duplication rate < 30% for WGS
Primary variant types SNPs, INDELs, structural variants (SVs), copy number variants (CNVs)
Recommended platforms Galaxy (user friendly web interface), Bioconductor (R based reproducible workflows)

Core Concepts

Genomic analysis begins with a biological sample whose DNA or RNA is fragmented, sequenced, and converted into millions of short reads (usually 100,300 base pairs). The two dominant sequencing platforms are short read (Illumina) and long read (PacBio, Oxford Nanopore). The choice affects downstream analysis. Short reads are cheaper and more accurate for single nucleotide variants (SNVs) but struggle with repetitive regions and large structural variants. Long reads can span repeats and detect SVs more reliably but have higher error rates. Therefore, selecting the correct sequencing approach is the first critical step.

After sequencing, the reads must be aligned to a reference genome. Alignment algorithms such as BWA MEM (for short reads) or minimap2 (for long reads) map each read to the best matching location. The resulting BAM file is then processed: duplicate reads are marked, base quality scores are recalibrated, and variants are called. Variant callers like GATK HaplotypeCaller or FreeBayes identify positions where the sample differs from the reference. For RNA seq, the process is similar but uses splice aware aligners (STAR or HISAT2) to account for intron junctions, and expression quantification may replace variant calling.

Bioconductor provides dozens of R packages for downstream analysis, including DESeq2 for differential expression, VariantAnnotation for variant interpretation, and topGO for functional enrichment [4]. Understanding these core concepts allows you to navigate the extensive training materials available from EMBL EBI [2].

Decision Points

Every genomic analysis project requires you to make explicit choices at several forks. The first decision is the type of sequencing. Whole genome sequencing gives the most comprehensive variant discovery but is expensive. Whole exome sequencing targets coding regions at lower cost but misses regulatory and noncoding variants. If your question is about gene expression, use RNA seq. If you are tracking a specific pathogen outbreak, amplicon based sequencing may be sufficient (see [11] for a family outbreak traced with targeted sequencing).

The second decision is coverage depth. For human germline SNV detection, 30x coverage for WGS is standard. For somatic cancer variants, you may need 100x or more to detect low frequency mutations. RNA seq generally requires 20,30 million reads per sample for adequate gene quantification. Underpowered studies waste resources and produce unreliable results. The NCBI Sequence Read Archive (SRA) provides public data to estimate coverage and read depth for similar experiments before you start [5].

The third decision is computational environment. If you lack programming experience, the Galaxy web platform offers a graphical interface where you can chain tools into reproducible workflows. The Galaxy Training Network has hands on tutorials covering everything from quality control to variant filtration [3]. For advanced users, command line tools and R/Bioconductor give finer control but require a steeper learning curve.

Practical Workflow

A robust genomic analysis workflow follows these six steps.

Step 1: Define the question and sample size. Write a concrete hypothesis. For example, "Do patients with specific metabolic risk factors carry the FGF1 gene polymorphism rs152524?" This example mirrors the study in [6]. Your sample size must be powered to detect the expected effect. Use published data or pilot experiments to estimate.

Step 2: Obtain or generate raw data. Upload your reads to a public repository such as the NCBI SRA. Download quality reports with FastQC. Check for adapter contamination, per base sequence quality, and GC bias. Remove low quality bases and adapters with Trimmomatic or cutadapt.

Step 3: Align reads to a reference genome. Download the reference from NCBI or Ensembl. Use BWA MEM for short reads (Illumina) or minimap2 for long reads. Convert the SAM output to sorted, indexed BAM files using SAMtools. Evaluate alignment statistics: mapping rate, insert size distribution, and coverage uniformity.

Step 4: Call and filter variants. Run GATK or FreeBayes to produce a VCF file. Apply hard filters based on quality score, depth, and strand bias. GATK's Best Practices workflow includes Base Quality Score Recalibration (BQSR) before variant calling. For population genetic and conservation studies in non model species, be wary of filtering tradeoffs that can bias downstream inferences, as demonstrated in a scallop case study [10].

Step 5: Annotate and prioritize variants. Use ANNOVAR or SnpEff to add functional effect predictions. For clinical interpretation, check allele frequencies in gnomAD and impact scores from SIFT and PolyPhen. For gene family studies, as in the phenylalanine ammonia lyase analysis in Chrysanthemum [9], homology based annotation may be needed.

Step 6: Validate and interpret results. Visualize candidate variants with IGV. Perform confirmatory Sanger sequencing for key findings. For expression data, run DESeq2 and follow up with pathway enrichment analysis, such as the metabolomic profiling done in selective intrauterine growth restriction [8].

Quality Checks

Without rigorous quality control, your genomic analysis is unreliable. At every step, check the following metrics:

  • Per base quality scores: Median Q score should be above 30 (99.9% accuracy). If not, consider trimming or discarding the lane.
  • Mapping percentage: For human WGS, >95% reads mapped is typical. Lower values indicate sample contamination or poor reference choice.
  • Duplicate rate: In WGS, a duplicate rate under 10% is ideal, above 30% suggests too many PCR cycles or low input DNA.
  • Transition/transversion ratio (Ti/Tv): For whole genome, expected ~2.0,2.1. A lower ratio may signal false positives.
  • Coverage depth distribution: Uniform coverage across chromosomes indicates good library preparation. Regions with zero coverage may be problematic.

The Galaxy Training Network offers a complete tutorial on quality control, including MultiQC aggregation [3]. Running these checks prevents downstream analysis from being built on noisy data.

Common Mistakes

Even experienced analysts make avoidable errors. The most frequent is overfiltering variants. Applying too many or too stringent filters can remove true biological variants, especially in non model organisms where reference genomes are imperfect. The recent tradeoff analysis in scallop genomics [10] illustrates how filtering decisions affect population genetic statistics. A second common mistake is ignoring batch effects when combining data from multiple sequencing runs. Always include technical replicates and use batch correction tools like ComBat in your differential expression or variant calling workflow.

Another pitfall is failure to validate with an orthogonal method. Variant calls from short read data, especially INDELs and SVs, have high false positive rates. Always confirm critical findings with long read sequencing or PCR. Finally, misinterpreting significance in large scale analyses: with millions of variants, p values must be corrected for multiple testing (Bonferroni, FDR). Without this step, many reported associations are noise.

Limits of Interpretation

Genomic analysis has inherent limitations that no amount of computation can overcome. First, reference bias: reads from a sample that differ substantially from the reference genome may not align well, leading to missed variants. This is especially problematic in populations underrepresented in reference genomes. Second, repetitive regions remain refractory to short read assembly. Even with long reads, centromeres and telomeres are difficult to resolve.

Third, functional interpretation is probabilistic. Predicting whether a missense variant causes disease relies on computational scores that have modest accuracy. The FGF1 gene polymorphism study [6] shows how associations with metabolic risk factors require careful adjustment for confounders. Fourth, causality cannot be established from genomic data alone. A variant may correlate with a phenotype but not cause it. Functional experiments (e.g., CRISPR editing) are needed for confirmation. As the botulism outbreak investigation [11] demonstrates, genomic tracing combined with epidemiological evidence is more powerful than either alone.

Frequently Asked Questions

What is the minimum coverage needed for reliable variant calling in humans? For germline SNV detection, 30x coverage is widely accepted. For somatic mutation detection in cancer, 100x or more is recommended to capture low allele frequencies. Always check the guidelines from the Genome in a Bottle Consortium.

Can I use the same bioinformatics workflow for RNA seq data? Not exactly. RNA seq requires a splice aware aligner (e.g., STAR) and a quantification step. However, many quality control steps and downstream statistical methods are shared. The Bioconductor package DESeq2 handles count based RNA seq data [4].

How do I handle a non model organism without a reference genome? Use de novo assembly tools (SPAdes, Flye) or align reads to a closely related species. For variant calling, proceed with caution, the tradeoffs are detailed in [10]. Alternatively, use transcriptome assembly as a proxy.

What should I do if my sequencing run has low quality scores? First, check if the issue is at the beginning or end of reads. Trimming low quality bases often helps. If the entire run fails, consider re sequencing. Raw data deposited in the NCBI SRA may be salvageable with aggressive trimming but at the cost of coverage [5].

References and Further Reading

Related Articles